Literature DB >> 20176578

Stability of meropenem and doripenem solutions for administration by continuous infusion.

Karine Berthoin, Cécile S Le Duff, Jacqueline Marchand-Brynaert, Stéphane Carryn, Paul M Tulkens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20176578     DOI： 10.1093/jac/dkq044

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  32 in total

1.  In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem.

Authors:  Cristina Tomasello; Anna Leggieri; Roberta Cavalli; Giovanni Di Perri; Antonio D'Avolio
Journal:  Hosp Pharm       Date:  2015-04-08

Review 2.  Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.

Authors:  Stephen John Perks; Cassie Lanskey; Niechole Robinson; Tilley Pain; Richard Franklin
Journal:  Eur J Hosp Pharm       Date:  2019-06-20

3.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

4.  Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.

Authors:  Neang S Ly; Zackery P Bulman; Jürgen B Bulitta; Christopher Baron; Gauri G Rao; Patricia N Holden; Jian Li; Mark D Sutton; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Short versus long infusion of meropenem in very-low-birth-weight neonates.

Authors:  Helgi Padari; Tuuli Metsvaht; Lenne-Triin Kõrgvee; Eva Germovsek; Mari-Liis Ilmoja; Karin Kipper; Koit Herodes; Joseph F Standing; Kersti Oselin; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

6.  Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.

Authors:  William A Prescott; Allison E Gentile; Jerod L Nagel; Rebecca S Pettit
Journal:  P T       Date:  2011-11

7.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

8.  Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function.

Authors:  Muhammad Usman; Otto R Frey; Georg Hempel
Journal:  Eur J Clin Pharmacol       Date:  2016-12-13       Impact factor: 2.953

Review 9.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

10.  A fluorescent carbapenem for structure function studies of penicillin-binding proteins, β-lactamases, and β-lactam sensors.

Authors:  Cynthia M June; Robert M Vaughan; Lucas S Ulberg; Robert A Bonomo; Laurie A Witucki; David A Leonard
Journal:  Anal Biochem       Date:  2014-07-21       Impact factor: 3.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.